Shire’s Vpriv website in breach of ABPI Code

Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct.  The complaint was bought by Sanofi’s subsidy Genzyme, which makes a ri…
Read the full story: InPharm